Effect of a fixed-dose combination of Telmisartan/S-amlodipine on circadian blood pressure compared with Telmisartan monotherapy: TENUVA-BP study

BACKGROUND: This study evaluated the circadian efficacy of a telmisartan 40 mg/S-amlodipine 2.5 mg fixed-dose combination (Telmisartan40/S-Amlodipine2.5) compared to telmisartan 80 mg (Telmisartan80) in patients with essential hypertension who did not respond to 2–4 weeks’ treatment with telmisartan...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Bong-Joon, Cho, Kyoung-Im, Kwon, Hyuck Moon, Choi, Seung-Min, Yoon, Chang-Hwan, Lim, Sang Wook, Joo, Seung-Jae, Lee, Nam Ho, Lim, Sang-Yup, Lim, Seong-Hoon, Kim, Hyo-Soo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886760/
https://www.ncbi.nlm.nih.gov/pubmed/35227313
http://dx.doi.org/10.1186/s40885-021-00184-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886760/
https://www.ncbi.nlm.nih.gov/pubmed/35227313
http://dx.doi.org/10.1186/s40885-021-00184-0

Ejemplares similares